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Background
Rare diseases are individually rare (affecting less than 200,000 people), and collectively
affect millions of people worldwide (Institute of Medicine (US) Committee on Accelerating Rare
Diseases Research and Orphan Product Development 2010a; NIH 2016; Shen et al. 2015).
Currently, the number of known, rare genetic diseases is around 7000 and it is suggested that as
many as 8000 rare genetic conditions have yet to be discovered (Dudding-Byth et. al, 2015;
Lambertson, 2015).
Over the last several years, advances in technology have made whole exome sequencing
(WES), a tool for diagnosing the previously un-diagnosable. In approximately 25-40% of patients
tested, WES has identified the genetic basis of disease (Sawyer, 2016). WES created a paradigm
shift in how both healthcare providers and researchers approach diagnosis of genetic disease
(Sawyer, 2016). Using WES, researchers have identified more than 180 distinct novel diseasecausing genes (Sawyer et al., 2016). However, rare variants within these genes are often labeled
a “variant of uncertain significance (VUS)” due to insufficient data available to determine their
effects on gene function and association with the patient’s phenotype. To determine causality,
functional studies can be performed, however these are expensive, fall outside the scope of
clinical diagnostics laboratories, and are rarely covered by insurance. Identifying a second
unrelated patient with overlapping phenotypic characteristics and the same variant can help link
a variant to a disorder, but there is currently no established protocol for using databases to
establish causality for these ultra rare diseases (Dixon-Salazar, 2012).
Due to the increasing use of whole exome sequencing, more individuals are now being
diagnosed with extremely rare conditions not previously reported in the medical literature
(hereafter referred to as “N-of-1” disorders) (Sawyer et al., 2016). N-of-1 diseases tend to be
severe, life-threatening, debilitating, and affect multiple organ systems. Patients often present

with multiple problems that may seem unrelated, and unfortunately, for such rare diseases little
is known about the natural history of the disease, and there are often no treatment or medical
management guidelines (Dudding-Byth et. al, 2015). They can impair physical, mental, and/or
behavioral capacities, and reduce one’s life expectancy (Schieppati, 2008). For N-of-1 disorders,
the variants and genes identified are by definition novel and unfamiliar, and may not allow
access to scientific and medical expertise (Hennekam, 2011; Dudding-Byth et. al, 2015). Ultrarare diseases, in general, lack management guidelines and information on natural history and
prognosis (Dudding-Byth et al. 2015). More than 95 percent of rare diseases lack a specific
treatment (Miyamoto and Kakkis 2011). However, a diagnosis validates the patients’
symptomatology, provides information about prognosis and may offer hope for the direction of
medical care in the future (Dudding-Byth, 2015; Krabbenborg et al., 2016).
The benefit of receiving a diagnosis extends beyond receiving specialized treatment. It
also affords families the ability to understand and label the condition and better cope with the
situation (Senger et al. 2016). A 2008 review in The Journal of Clinical Genetics, describes
patients’ adaptation to living with a genetic condition, and explores the process of coming to
terms with the implications of a health threat, that “a diagnosis is initially disruptive and leaves
parents or an individual feeling out of control. They seek ways to regain feelings of control by
learning as much they can about the condition, taking control over aspects of medical care.”
(Biesecker et al., 2008). The emotional, medical, and psychosocial impact of rare diseases on the
patient and their caregivers is compounded for those with N-of-1 disorders; parents become the
real experts of these ultra-rare disorders and related therapies (Schaffer et al. 2008; Budych et
al. 2012). Due to the low prevalence of each individual rare disease, parents of children with
rare diseases report having high stress and emotional demands related to feelings of
incompetence and social isolation (Dellve et al. 2006). The “surrounding psychological desert” is

distressing for N-of-1 individuals and their families, who cite a lack of support, even once they
had received a diagnosis (Anderson et al. 2013; EURODIS 2009). Families impacted by a rare
disease experience more psychosocial stressors than those affected by comparable, less rare
conditions (Schieppati et al., 2008). The nature of the illness can present overwhelming
challenges to parents who bear daily responsibilities for managing their child’s care, while
holding at bay this pervasive fear for the child’s well-being, and experiencing feelings of guilt
and personal failure (Senger et al. 2016). Furthermore, parents of children with complex medical
conditions often carry extraordinary burdens, both visible and invisible, associated with care.
Senger et al. describes how parents are called to advocate for their child while navigating a
complex health care system, “The visible demands of caring for a chronically ill child […] include
the technical day-to-day aspects of in-home medical care, sophisticated clinical judgment, and
vigilant monitoring of symptoms. The invisible demands […] include worry and fear about the
unpredictable nature of the illness trajectory, public reaction to the child’s disability, and
wondering how their child will fit into the world, gain acceptance, and make friends.” (2016).
In the literature, a frequent theme described by parents as being essential was meeting
other families with children diagnosed with similar conditions, and gaining a sense of control
over an uncontrollable situation. Patients and caregivers tend to seek social support by joining
support groups, striving to find ways to meet their own or their child’s needs, which ultimately
has been shown to be associated with positive adaptation across a variety of chronic conditions
(Biesecker et al. 2008). A 2016 NPR article, “Families Isolated by Rare Genetic Conditions Find
New Ways to Reach Out,” centered on families affected by a rare genetic disease, and how they
find ways to search for others with their same condition. The article explored families’ sense of
isolation; they described how having a child with an illness that is likely genetically based, yet
never before described in the scientific literature, landed them in “an information desert.” They

explained how research protocols tend to keep scientific findings quiet until they are published,
or how health privacy laws prevent a genetics lab from connecting two families who have the
same mutation. One parent noted, “These days there are ribbons and awareness weeks for so
many diseases, […] but when yours is ultra-rare, you feel completely isolated. You feel like
you're never going to hear another person say, 'Us, too!' And being connected to other families
changes all that." (Snow, 2016). A recent 2016 study in the Journal of Genetic Counseling,
examined the need for families to connect to other families with the same diagnosis, through
the use of Facebook, social media, and other forms of online community support. One parent
stated, “The information we have been able to get has been through other families […] We even
had [an] awareness day earlier this month […] We are able to meet people that were 50 years
old and that are diagnosed with [X] syndrome. You know, it is such a wonderful thing to be able
to see sort of the future or the possibilities of the future.” (Rosell et al. 2016). The supports that
would normally be provided by disease communities, which aim at gathering and disseminating
the limited existing information on their disease, and connecting patients and families, do not
exist or are not geared towards an N-of-1 diagnosis. For all these reasons, significant gaps exist
for N-of-1 families.
Existing literature on rare diseases is highly disease oriented and technical, primarily
originating from the research of medical specialists. Rare disease patients believe the
information they receive from health professionals at the time of diagnosis is insufficient, thus
motivating their engagement in online research (Gundersen 2011). Parents use of the Internet
to search for information, and engagement in online communities are important ways parents
often manage uncertainty and stress regarding their child’s health condition (Oprescu et al.
2013). It is estimated that 56.3 million people in the US use the internet to search for
information about chronic diseases, and this information affects their decision-making regarding

their health (Dutta-Bergman 2004; Rainie et al. 2003). Approximately 79 million Americans are
members of online support groups, with an estimated 1 in 4 people who join discussion groups
while searching for disease information (Levy and Strombeck 2002; Rainie 2005). Individuals
benefit from online health communities by receiving informational and emotional support, and
many find the opportunity to share their own experiences and provide support to others
rewarding as well. Cyber-based health forums allow families within a disease community to help
one another identify specialists whose research is dedicated to a specific condition, and who
may be willing to read an e-mail, give an opinion, or even possibly make an appointment for a
consult (Eby, 2015). Patients who feel empowered have been shown to be more capable and
effective at managing their health conditions, accessing care, and communicating with
healthcare professionals (van Uden-Kraan et al. 2009). Online support communities offer several
other advantages including lack of geographic restrictions, 24/7 availability, and a degree of
anonymity (Oprescu et al. 2013a). Ultimately, there are few studies examining the impact of
Internet support groups in the rare disease population, and even fewer catering to N-of-1
individuals specifically, thus highlighting the need for further research.
The goal of our project was to create a website that could be offered as a resource to
individuals and families within the N-of-1 disease community. This resource would include userfriendly how-to guides that would help families navigate existing genetic databases and provide
tools to advocate for themselves through social media campaigns. In constructing this website,
we hoped to provide individuals with an N-of-1 diagnosis assistance in finding others in similar
situations and establishing support communities.
Our Process
We believed it was important to provide families with a central resource that
aggregated all existing resources. These families are often managing difficult lifestyles, balancing

busy schedules and family members’ healthcare, and may not have the time to sort through
resources, or know where to start. In order to make our website as useful and accessible as
possible for visitors, we identified the ways in which individuals with a genetic disease and their
families use the internet for information and support. We began by reviewing online resources
currently available, and collectively assessed the benefits and limitations specific to the N-of-1
community for each resource. Many resources were found through Google searches, prior
knowledge of resources through working with other genetic professionals, or previously
successful support community initiatives by N-of-1 individuals and their families. Based on this
analysis, we identified which websites to include and among those, which required step-by-step
instructions. Primarily, these resources permitted individuals and their families to share their
information online through various social media platforms or online databases that matched
individuals based on their genetic information. For each resource that allowed individuals with
an N-of-1 diagnosis to connect with others based on genotype or phenotype we created a howto guide. Our goal was to provide a wide range of options to increase the chance of successfully
connecting individuals or families.
There is a direct relationship between active participation on social media and the
likelihood of making useful connections (Baruah, 2012). How-to guides for Facebook, Twitter,
Wordpress, Reddit, and Wikipedia were all chosen to allow members with an N-of-1 diagnosis to
create their own social media campaigns and empower them to tell their own story. We
reasoned that these how-to guides are good starting points for N-of-1 individuals since most are
already registered users of one or more. For individuals that currently do not use any social
media the how-to guides aid them in setting up a profile on various social media platforms,
begin potential promotion, and community building.

Another category of resources are databases that allow individuals or family members
to enter specific genetic and/or clinical information, hopefully matching them with others from
around the world. Since N-of-1 diagnoses are so incredibly rare, it is important to expand
searches beyond a local geographical region. By participating in large-scale databases like
MyGene2, GenomeConnect, and Undiagnosed Diseases Network, these individuals have the
opportunity to be matched with someone from anywhere in the world. While these websites
and databases can be useful for finding N-of-1 individuals, they are also difficult to navigate.
They require a baseline understanding and ability to describe the condition, and genetic
information that often requires the assistance of medical professionals and laboratories. We
provide assistance through our how-to guides in making these resources accessible to N-of-1
families.
The last group of how-to guides included were online resources that could be used by
the N-of-1 community to better understand their condition, and to keep up to date on any
scientific research following a diagnosis. Many of these are potentially useful, but require
scientific literacy and knowledge of specific nomenclature that could present an obstacle for
many families or individuals. Therefore, we created how-to guides to be used as companion
resources to Google Alerts, Human Phenotype Ontology (HPO) and PubMed.
Simplicity was key in the creation of the how-to guides, while still clearly describing a
complicated process. How-to guides required multiple screenshots illustrating the step-by-step
process one would take when navigating the resources. We wanted to ensure that the guides
were easy to follow. This was done by including red arrows, boxes, and text boxes on the
pictures so users would know exactly where to look to find the information required to move
forward. Each guide was initially made by one group member, followed by multiple rounds of

edits by other group members and advisors. An example how-to guide can be seen in Appendix
A.
Additionally, we provided brief resource summaries for SWAN, PEER, Global Genes, Rare
Disease Day, ClinVar, ClinGen, OMIM, Genetic Alliance and NORD. We believe it was useful to
bring an awareness to these resources for the N-of-1 community, but also recognized they were
primarily geared toward other, more “traditional” rare disease audiences, healthcare
professionals, researchers, and clinical laboratories. While our primary goal was to focus on
resources that would help connect N-of-1 families to each other, we also wanted to put other
carefully selected, relevant educational and informative resources in one place. We also
provided an external link to the NIH’s genome.gov, a web-based tool that provides a thorough
and detailed genetics glossary. We felt it could be beneficial for individuals in the N-of-1
community to strengthen their understanding about genetics.
When naming the website and identifying potential branding opportunities, we wanted
to find something that would encompass the uniqueness of individuals in the N-of-1 community.
We also wanted a name that could become a symbol for the community as a whole. While
researching available resources, we read many patient stories to better understand what some
of these individuals and their families experience. The unicorn embodies the hopeful thought
that even though you have not met someone with your disease, it does not mean they do not
exist. It is also a symbol that equates rareness with something special and beautiful, rather than
isolation and bad luck.
Once we established a name and logo for the website, DNA unicorn, we researched
potential website domains. Our top priorities when choosing a website builder was ease of use
and price point. Potential website builders we evaluated were Squarespace, Wix, Weebly,

Wordpress, and eHost. We chose Squarespace because it was relatively user-friendly, and
provided video tutorials, as well as additional links to help navigate the system. Squarespace
provided dozens of templates to choose from, thus enabling us to customize the website to our
needs. These customizable templates provide a certain level of control, and come with built-in
integrations, so that adding plug-ins, links, and files like PDFs, can be done directly on the
website. Our focus when picking a template was to choose one that allowed us to upload
multiple PDFs into one page while still being able to organize them neatly in an order we felt
most desirable. Squarespace also offers free unlimited hosting, meaning there is no limit to the
site's storage and bandwidth. This was important for any potential future growth of DNA
Unicorn. Lastly, of the many domains we researched, Squarespace was one of the most
affordable, providing a student discount with a two-year subscription.
Upon completion of the website, a beta version was sent to fourteen genetics
healthcare professionals for their feedback. We received feedback through a seven-question
survey. We asked participants to evaluate the aesthetics, language and content of the website,
and of the specific how-to guides. Based on the feedback that we received, we incorporated
appropriate changes to the website.

Below we will discuss each resource that is featured on our website, their purpose,
strengths, limitations, and utility within the N-of-1 community.

Matchmakers
MyGene2: https://www.mygene2.org/MyGene2/
MyGene2 is a patient portal designed to assist families in finding a community of those
with the same rare disease diagnosis. MyGene2 can be accessed by families, clinicians, and
researchers to input medical and genetic information that can be shared with others. Families

and the MyGene2 matching system can search up to date profiles to look for matches based on
phenotype, gene mutation, or ideally both. Furthermore, MyGene2 is linked to Match Maker
Exchange (MME). MME is a large patient database that increases the chance of finding a match
since it searches through a larger pool of affected individuals.
Because both families and healthcare professionals can access MyGene2, it can be a
good place for a variant or candidate genes to be confirmed as the cause of a condition. If
MyGene2 matches families with the same candidate gene or overlapping clinical characteristics,
researchers who access the database can interpret the pathogenicity and causality of that
particular gene or variant, and subsequently study possible genotype-phenotype correlations.
Confirmation of a diagnosis allows healthcare professionals to provide more appropriate
expectations and medical management, thus informing and assisting families’ medical care and
decision-making.
While MyGene2 is relatively easy to navigate for N-of-1 families, problems can arise
when submitting genetic information. MyGene2’s application form and instructions use
scientific language that may be challenging for families to understand. Because of the complex
nature of the genetic test results, and the language used on MyGene2’s application, there is
room for error or misinterpretation when submitting the information. This poses a problem, as
the matches rely on the accuracy of the genetic information provided. To ensure the
information entered matches both their genetic test results and clinical picture, and thus
assuring an appropriate match, families may need to seek the assistance of their healthcare
provider
The Undiagnosed Diseases Network: https://undiagnosed.hms.harvard.edu/

The Undiagnosed Diseases Network (UDN) is targeted to those individuals who have yet
to receive a genetic diagnosis explaining the cause of the symptoms they experience. This
patient population is affected with disorders that have not been diagnosed using conventional
genetic testing methods.
The UDN’s goal is to encourage collaboration between clinical and research experts at
top institutions across the United States, and to solve challenging undiagnosed cases that
burden individuals and families. The UDN aims is to help individuals and their families
understand the nature of their disease and to connect with others who are similarly affected.
When submitting an application, the UDN system is simple to navigate for families
without a science or medical background. Additionally, the UDN provides great resources that
outline topics including the genetic testing process, and how to find similarly affected individuals
online. One drawback of the UDN system and application process is that patients and their
families require supporting documentation from their healthcare provider. Providers must have
a referral letter outlining previously completed testing and a summary of the patient’s
symptoms. While this ensures a higher percentage of applications are appropriate for the
overarching goal of the UDN’s mission, it can be a barrier for families who wish to enrol but
whose providers did not submit the required information.
As more individuals are completing applications and being accepted into the network,
there is an ever-growing list of candidate genes being discovered. While the main goal of the
study is to increase understanding about the genetic contribution to human disease, the UDN
makes an effort to support families following a diagnosis. UDN recognizes that having a rare
diagnosis is isolating and taxing on families, and works to combat that through social media
exposure (Dellve et al. 2006). Once a diagnosis is confirmed, UDN will assist families in creating a

profile that will outline their symptoms, diagnosis, and personal stories. Families are consulted
about how much or how little information they are comfortable sharing and once completed by
the UDN, that profile can be shared on their website and various social media platforms (i.e.
Reddit, Facebook, and Twitter). The profiles created by the UDN are similar to ones we have
outlined in DNA Unicorn through how-to guides. The limitation of social media campaigning
through UDN’s platforms is that they can only be discovered when looking at the UDN website
or social media pages.
GenomeConnect: https://www.genomeconnect.org/
GenomeConnect is an online registry and database that allows users to securely and
confidentially share their health data and genetic test results. By sharing information through
GenomeConnect, users add to the knowledge base of genetics, health, and the relationship
between the two domains. This knowledge assists physicians and researchers in understanding
the genetic basis of certain diseases and aids in the development of treatments.
GenomeConnect now has a Participant Matching System that users can opt to join. The
Participant Matching System helps users connect and find others with a similar diagnosis.
GenomeConnect is open to all adults (18 or older) and users must meet one of the following
criteria: have already had genetic testing, are considering genetic testing, or are family members
of someone who has had genetic testing. This resource, alongside MyGene2, is one of few that
exist for the purpose of matching users based on genetic and phenotypic data using a secure
portal. It can be time-consuming for users to enter phenotypic data, especially if multiple organ
systems are involved, but this is necessary in order to best match with others.
The Participant Matching System is a new part of the GenomeConnect resource, which
means that at this time the number of enrolled users is likely still relatively small. Additionally,

because this is a newer feature of GenomeConnect, fewer health care providers are aware that
it exists and may not be directing their N-of-1 patients to the website. The more people
participate, the more the database will grow, increasing the number of matches. This resource
appears to only be available in English, so users around the world may have difficulty accessing
GenomeConnect. It will be important to engage users around the world, especially with N-of-1
diseases because of the extreme rarity of each individual disease.
PEER: http://www.geneticalliance.org/programs/biotrust/peer
Platform for Engaging Everyone Responsibly (PEER) is an online platform offered
through the Genetic Alliance that allows people to electronically share their health data for
research. Anyone, regardless of his or her current health, can register and enter health data.
Physicians and researchers also register to be a part of PEER and create profiles so that
participants understand their areas of research and practice. Participants can decide which
researchers, physicians, and organizations are allowed to access their contact information and
data, and what specific data they can have access to. Participants are able to change their access
settings at any time. Different disease advocacy organizations can create their own portal and
community within PEER. Participants can register for PEER through an existing disease
organization portal or as an individual independent from an advocacy organization. PEER can be
used by participants to connect with researchers and physicians who have research interest in a
specific gene or type of disease and help add to their knowledge base. Through PEER
participants may also find a clinical trial or physicians that have expertise in treating a specific
type of disease. PEER has community-based examples to help users decide what information to
share. The community-based examples are guides developed by PEER users affiliated with
specific disease advocacy organizations to help people choose their privacy settings. At this
point PEER only has around 45 disease-specific communities. N-of-1 families would have to sign

up as an individual, a feature that currently offers less guidance on registering and selecting
privacy settings. While PEER has the potential to be an excellent resource for many N-of-1
families, it is currently being updated and the link to register for PEER as an individual is
currently unavailable.
Social Media
Social media is a type of electronic communication using websites and applications that
allow users to create and share content, and to network with others. Social media websites are
useful for sharing personal stories and campaigns across the world for free. They can be
accessed anytime, by anyone with a device or personal computer, and anywhere as long as an
Internet connection or mobile network is available. The story of Bertrand Might is an example of
how social media can be used successfully to share a rare disease story in order to identify other
individuals with the same gene and phenotype to create a rare disease community (Mnookin,
2014). When Matthew and Cristina Might’s son Bertrand was diagnosed with an N-of-1 genetic
disease, Matthew wrote a powerful online essay on his already popular blog detailing his
family’s experience and shared it on Reddit (Might, 2012). Within 24 hours the essay had gone
viral, was shared on several social media websites, and was the top story on Reddit (Mnookin,
2014). Through sharing his family’s story, Matthew Might was able to find other individuals
around the world with the same genetic disease as Bertrand, thus creating a community for
himself and others. To help other families utilize social media to effectively find others with the
same N-of-1 disorder, we created how-to guides for four popular social media websites:
Facebook, Twitter, Reddit, Wordpress (blogs), and Wikipedia.
Facebook: https://www.facebook.com/

As of July 2016, Facebook had 1.71 billion monthly active users worldwide (Fiegerman,
2016). Anyone with Internet access and an email address or phone number can create an
account on Facebook, although there are minimum age restrictions in some locations. Users can
send “friend” requests to other users, which allows them to see each other’s posted content.
Registered users are able to post text, pictures and videos, files, privately message others, and
join private or public interest groups. The ability of anyone to create a group is especially useful
for N-of-1 families because they can use this function to create their own support communities.
The person who creates a group has the ability to decide who can join and what content is
shared within the group. Also, there are privacy settings that can be adjusted to allow only
group members to see the content shared on the group timeline. This is particularly useful when
discussing personal health information or posting photos of minors.
Facebook has a help center that explains its many features and applications in a simple
way. It is easy to set up a personal account and a group in minutes. As with most social media,
some individuals may post controversial and offensive content. A Facebook user does have the
ability to report offensive content and block those individuals who post it. Another limitation is
that messages are only seen by friends unless they are shared. If a user does not have very many
active Facebook friends their message may not make it very far. A Facebook post can be made
“public” allowing any Facebook user to see it, which could help individuals reach a wider
audience.
Twitter: https://twitter.com/?lang=en
Twitter is a social media platform where users post content, called “tweets,” to their
timelines. Tweets are limited to 140 characters and can be linked to articles and videos. Users
can follow others and be followed, and you are able to view many accounts without being a

registered user. Registered users can “reply” publicly to another user’s tweet and direct private
messaging is also available to individuals who follow each other. In addition to social
networking, Twitter can also be used to find out about current events and news from around
the world. As of June 2016 Twitter had 313 million active users
(https://about.twitter.com/company). Organizations can also create Twitter accounts to interact
with and keep their followers up to date on the organization. Making a Twitter account takes
very little time. For those who want it, Twitter allows for some degree of anonymity because
sharing personal information is not required. On Twitter, users can search for topics of interest
and see tweets pertaining to a particular topic. For N-of-1 families, Twitter could be another way
to share their stories, to search for others, and to stay updated with news and events from rare
disease organizations. While Twitter is useful for staying updated on current events, Twitter
must be checked frequently, especially if following multiple accounts as their timelines will be
constantly changing. Additionally, a tweet is limited to 140 characters, so users must be succinct
and thoughtful about word choice to maximize the impact of a tweet. It can be difficult to tweet
about more detailed or complicated subjects.
Reddit: https://www.reddit.com/
Reddit is a platform that allows it’s online community to rate and discuss web content
posted by its users. According to recent Reddit web traffic statistics, as of November 2016,
Reddit had over 100 million monthly visitors (12 million unique users)
(https://www.reddit.com/r/AskReddit/about/traffic/). The website has a rating system that
allows registered Reddit users to “upvote” or “downvote” content based on their opinion of
whether a post contributes to the conversation or not. Per Reddit, “Through voting, users
determine what posts rise to the top of community pages and, by extension, the public home
page of the site.” (https://reddit.zendesk.com/hc/en-us/articles/204511479-What-is-Reddit-).

Content ratings will determine the level of success and visibility each post receives. There are
discussions and posts on Reddit that cover a large number and wide range of subjects. Reddit is
different compared to other social media platforms in that by voting, the users have an active
role in deciding the content that appears at the top of each page (this is the content that is the
most popular). Furthermore, in Reddit users can participate in open discussion forums with
more anonymity than Facebook. With Reddit it is easier to have a discussion about a particular
topic than it is on Twitter because the user is not limited to a 140-character post. Reddit can be
a good source for sharing complex personal stories and creating a common interest community.
The example of Matthew Might illustrates the power of Reddit in sharing a story around the
world. However, Reddit is not user friendly and it takes a significant amount of time to learn to
use all of its features. Additionally, there are certain parts of Reddit that are not accessible
unless the user has enough “Karma points”, which are gained through consistent use and voting
on posts. A user has to be sufficiently active in the Reddit community to gain the Karma points,
meaning they have to make a significant contribution to the site before being able to access the
full benefits of the platform.

Wikipedia: https://www.wikipedia.org/
Wikipedia is an online encyclopedia that is written by people individually or in
collaboration. Wikipedia is a resource that N-of-1 families can utilize to distribute information
about a given condition. Individuals can share educational information about gene structure and
function, or the symptoms, management, and possible therapies of a defined disease. The hope
for N-of-1 families is that a Wikipedia page can educate people who search for the gene or
disease. Wikipedia is a great platform for these families to start with as it is used on a global
scale, and places near the top of most Google or other search engine results.

Wikipedia does pose some challenges for first time users, specifically regarding the
guidelines for what is and isn’t allowed. Wikipedia does not permit users to create a Wikipedia
page about themselves for any personal campaign. Therefore, if users are affected by an N-of-1
disease and decide to create a Wikipedia to share their story, they would be in violation of the
websites policies. Affected individuals can work around these restrictions by creating Wikipedia
pages about the gene or condition they are affected by. Wikipedia does allow individuals to
create pages about other people. Therefore, families can create Wikipedia pages about the gene
change that caused an affected family members symptoms and their journey to finding a
diagnosis and effective management.
Wikipedia is relatively simple to use in its most basic format. It is a resource that all
families should be able to utilize to promote their condition in order to create an N-of-1
community. When adding additional features to the Wikipedia page some coding is required
which complicates the process considerably. Coding is required to change the font or color of
the text, as well as to insert images, video, and other links. These features are fundamental to
creating an effective Wikipedia that captures an audience when establishing an N-of-1
community.
Blogs: https://www.wordpress.com/
Blogs were created to allow individuals to express themselves online in a form of an
online journal. Since then, blogs have evolved into a platform for company press releases, artist
portfolios, a space for businesses to engage their clientele, and countless other purposes. Using
a blog to document one’s life gathers like-minded curious readers. As blog sites have developed,
bloggers are able to establish connections with their readers and create virtual communities.
There are a myriad of different blog-creating websites that allow users to create blogs that suit

their needs. Often these blogs range from the free and easy to use, to more complicated
versions with monthly fees. These websites provide a domain name, templates, and blog
builders that allow users to customize their blog based on their needs and personal style.
Creating a blog can be overwhelming, but the process is simplified when choosing a website
builder with easy to use templates and clear instructions. Regardless of the blog users choose,
there will always be some degree of trial and error involved in the creative process. Our how-to
guide focused on using Wordpress to create a free blog. Despite the free templates being
simple, and not having options available to those with a monthly fee (i.e. removing Wordpress
advertising, site storage, monetizing abilities, and advanced design tools), it is sufficient for the
purposes of spreading awareness regarding N-of-1 diseases and establishing support
communities.
Once users have created their blog, it needs to be continually edited to suit their
changing needs, as well as updated with new content to allow readers to view and follow their
journey. For N-of-1 families, blogs can be used to share their diagnostic odyssey, daily struggles,
and triumphs in order to form connections with similarly affected individuals. A blog can also be
used as a therapeutic outlet. Blogs work best for these individuals and families when they are
open and forthcoming with personal genetic information and stories regarding their diagnosis.
The more information provided, the more likely someone will read it and correctly identify
themselves as being similarly affected. Blogs can be beneficial in that they allow one’s struggles
to be heard, but the ultimate aim of the blog how-to guides was to facilitate the blog’s ability to
build a community.
Scientific Literature and Databases
PubMed: https://www.ncbi.nlm.nih.gov/pubmed/

PubMed is a free, searchable, online database that houses abstracts and links to
publications in the life and biomedical science literature. While PubMed is a valuable resource
that is updated daily by the United States National Library of Medicine and the National Institute
of Health. Its target audience is healthcare providers, researchers, and those in academia.
PubMed is more successful when one knows what they are searching for and can enter in search
terms that yield appropriate results. Success with PubMed is minimal when the user is entering
combinations of keywords on a trial and error basis. For many N-of-1 families, this trial and error
process is their only option. This is further complicated by the fact that PubMed does not freely
supply the literature in its library to all users. Many journal articles come with a hefty and
unrealistic price tag for the average N-of-1 family. Those who remain undiagnosed are able to
search combinations of unique clinical identifiers in the hopes of finding literature on a
condition that matches theirs. However, this approach is often unsuccessful and time
consuming. For those who do receive a genetic diagnosis following testing, that genetic variant
can be searched within PubMed, and the results may provide a good starting place if families are
interested in contacting researchers or following developments in the field. The weakness of
PubMed is that it does not cater to a lay audience, thereby limiting the use of its extensive
library for most of those with N-of-1 disease. Lay users may find it helpful to share their findings
on PubMed with their healthcare providers assistance.
Gene Reviews & OMIM: https://www.ncbi.nlm.nih.gov/books/NBK1116/ ;
https://www.omim.org/
Gene Reviews and Online Mendelian Inheritance in Man (OMIM), much like PubMed,
are resources that are likely to be challenging to understand for individuals who do not have a
background in clinical and molecular genetics. GeneReviews is an international point-of-care
resource tailored to busy clinicians that provide clinically relevant and medically actionable

information about inherited conditions. OMIM is a well-referenced online catalogue of human
genes and genetic disorders. Both resources contain an extensive library of well documented,
peer-reviewed, and up to date information on genetic conditions or genes associated with
medical conditions. However, by definition, N-of-1 genetic conditions are absent from the
literature due to a lack of any well-documented cases, as well as uncertainty as to the
pathogenicity of candidate genes.
Additionally, these resources’ target audience is medical professionals and researchers.
While Gene Reviews does feature drop-down boxes that provide simplified definitions for
various words to accommodate a lay audience, information may be too complicated for the
average individual. OMIM pulls together the published literature and research regarding on a
particular condition or gene, which unfortunately does not always apply to N-of-1 conditions. Of
the information OMIM does provide, much of it would not be appropriate for a lay audience.
HPO and Phenomizer: http://human-phenotype-ontology.github.io/:
http://compbio.charite.de/phenomizer/
The Human Phenotype Ontology (HPO) is a project in partnership with the Monarch
Initiative that is directed at standardizing the medical/scientific terms used to describe
phenotypes associated with human disease. The initiative uses the scientific and medical
literature, and resources such as OMIM, DECIPHER, and Orphanet to build the HPO database.
Each of the terms in the HPO describes a specific phenotypic feature, and is associated with a list
of synonyms that includes the “lay person” terms commonly used to describe the feature. A
definition of the term is often included. The HPO was designed for use by clinicians and
scientists; however, the HPO is available to freely use online and may be helpful for N-of-1
families when trying to determine medical terms to describe the affected individual’s

phenotypic features. The HPO has approximately 11,000 terms as of Feb. 2017 with new terms
continually being added (http://human-phenotype-ontology.github.io/about.html). The HPO is
difficult to navigate and use; it takes a significant amount of trial and error for the user to
understand how to efficiently use it. Additionally, not all terms in the HPO have had a definition
added to their respective pages yet. That being said, this resource can be helpful when entering
data into matchmaking databases such as GenomeConnect or MyGene2 to ensure that standard
terminology is being used when entering phenotypic information.
The Phenomizer is a database of diseases that can assist in the diagnosis of a disease
based on phenotype. HPO terms are applied to the diseases that are in the Phenomizer
database. The Phenomizer was designed to assist physicians in creating a list of differential
diagnoses during a diagnostic work up. Entering the phenotypic features of a patient produces a
ranked list of possible diagnoses. Again, this tool is freely available to the general public so it can
be accessed by anyone, but it is most useful for individuals who are more scientifically inclined.
The Phenomizer may be used by individuals and their families who are still searching for a
definitive diagnosis that explains their phenotype. Like the HPO, the Phenomizer is difficult to
use and is easier to navigate/understand if the user has a medical background. If people without
a medical background are using this resource they will likely need to consult with a medical
professional before knowing how to proceed based on the list of possible diagnoses generated
by the HPO. Additionally, the HPO list does not include every possible diagnosis, which is
important to keep in mind when considering a differential diagnosis.
ClinGen: https://clinicalgenome.org/
ClinGen is a National Institutes of Health (NIH)-funded initiative dedicated to building a
central resource that defines the clinical relevance of genes and variants for use in precision

medicine and research. ClinGen has different working groups that focus on generating and
maintaining the numerous resources, tools, and registries that are linked through the ClinGen
website. The registries associated with ClinGen (such as GenomeConnect, described previously)
share genomic and phenotypic data in a centralized database for research and clinical use.
ClinGen aims to standardize how variants are interpreted, implement evidence-based guidelines
and develop algorithms for variant interpretation. The centralized databases will also improve
our understanding of variants in diverse populations, determine the clinical validity of variants,
and give an indication based on expert opinion of whether or not the information will alter
clinical management of patients. The content and functionality of ClinGen were designed to be
used by scientists and clinicians, and individuals and families may benefit more from ClinGen by
bringing it up for discussion with their providers, rather than utilizing it on their own.
ClinVar: https://www.ncbi.nlm.nih.gov/clinvar/
ClinVar is a NIH-funded project that is partnered with ClinGen. ClinVar is a database that
archives information on genomic variants and reports on their interaction with human health.
Clinical laboratories, expert panels, professional societies, and researchers submit variants to
ClinVar and rate each one on a scale of benign to pathogenic based on their own observations
and ranking system. ClinGen uses ClinVar as a source of variant data. ClinGen expert panels
review the variant data and submit standardized interpretations to ClinVar that provide
estimates of pathogenicity that also indicate a confidence level for the call. ClinVar provides a
conflict report of any differences in interpretation between their submitted variants and those
already in the database. ClinVar thus facilitates communication about the relationships reported
between genomic variation and observed health status/pathogenicity. ClinVar is free to the
public. If an individual has a variant identified by genetic testing, they can search for the variant
in ClinVar. If the variant is there, individuals can read more about its interpretation. ClinVar is a

resource individuals can consult when trying to determine the pathogenicity of a variant,
however, the user must be able to understand the ranking system for both the variant and the
levels of evidence. In addition, ClinVar can be confusing to use because sometimes there are
multiple pages for the same variant; the nomenclature must be exact, so there is no room for
error when entering the variant you are searching for.
Patient Advocacy Organizations
SWAN: http://swanusa.org/
Syndromes Without A Name (SWAN) is an organization that offers support to affected
individuals and their families who have yet to receive a diagnosis. SWAN advocates for changes
in the medical community that will support individuals who are undiagnosed. This is a critical
resource and initiative because those who are undiagnosed often lack appropriate treatment
options. This subset of people who remain undiagnosed do receive research dollars that might
help them develop better therapies or management guidelines. SWAN provides great resources
for families who are in this position, as well as travel grants that allow them to participate in
research or testing opportunities they may not be able to afford otherwise. While SWAN is not
targeted to the N-of-1 community, it still is a resource that families may find useful and easy to
understand.
GlobalGenes: https://globalgenes.org/
GlobalGenes is a non-profit rare disease patient advocacy and support organization that
was started in 2009. GlobalGenes aims to reduce the challenges of rare diseases for people
around the world by giving the rare disease community a unified voice. They provide resources
to help educate and create awareness of rare diseases. Their resources are designed to
empower rare disease patients and their families to become self-advocates. Over 500 global

organizations are affiliated with GlobalGenes. GlobalGenes provides toolkits for families that
cover a wide variety of topics, from how parents can advocate for their children with a rare
disease in the school system to a toolkit specifically for people who have not yet been
diagnosed. The organization also provides webinars, documentaries, information on drug
development, fundraising campaigns, and a patient impact grants. The information provided
that promote self-advocacy is especially important and useful because it applies to all rare
diseases. GlobalGenes does not have information that is specifically targeted at N-of-1 rare
diseases and thus does not specifically address the very unique challenges that these individuals
and their families face.
Other
Google Alerts: https://www.google.com/alerts
Google Alerts is a notification service that provides alerts whenever a given topic is
mentioned on the internet. The goals is to keep its users informed on new material as it is
published. Google Alerts allows users to create searches for any keyword(s), tailor the results
based on the source of the publication, and indicate how filtered the results will be. Google
Alerts searches through blogs, news outlets, websites, videos, books, and forums. Users can
modify their alerts to search through one publication source, or a combination of multiple
sources. Alternatively, users can choose “Automatic” which allows Google to curate results
based on what they think is most relevant to their needs. Results can also be filtered based on
region of publication, language, and frequency of alerts.
Google Alerts can be utilized by anyone, and is particularly useful for N-of-1 families.
Having a family member affected by a rare disease can be burdensome, and taking the time to
search the internet for useful or relevant resources is not always realistic. Google Alerts

eliminates the time individuals and their families would have spent sifting through news stories,
trying to stay up to date on new developments. While Google Alerts can be very useful, users
can quickly become overrun with excess information and an overwhelming number of emails.
Modifying the search options is critical. To avoid this, the frequency and quality of alerts should
be set to ensure that emails are being received in manageable intervals, and that they contain
only the best results. Unique identifiers related to an individual’s disease are encouraged as
keywords when curating one’s search options. This could include genetic testing results (either
the gene or the gene and variant) or distinctive symptoms. Ultimately, Google Alerts is only as
useful as the information available, and the effort put forth by the user.

Discussion
Limitations
We created and designed our website to be both a user-friendly and comprehensive
resource that N-of-1 families can utilize. We recognize, however, there are many limitations to
this process and to our final product. There is a lack of research on the specific needs of N-of-1
families and, without further evaluation, we cannot be confident that we have addressed those
needs sufficiently. Our survey of genetic healthcare professionals specifically asked for
constructive criticism regarding specific changes each respondent would make to the website.
These survey questions were not formatted in a way that would give a balanced representation
of the utility of the website. Until we receive feedback and evaluations from N-of-1 families, we
are not able to accurately assess its helpfulness and overall utility.
Currently, we are not affiliated with bigger rare disease advocacy organizations that
could increase traffic to the website, as well as build a reputation as a legitimate resource. At
present, we have no personal contact with the N-of-1 patient population, hindering our ability

to promote our resource with this population directly. As four graduate students in genetics, we
also lack a lot of expertise in web design and other related aspects, such as search engine
optimization. A final limitation of our website is that it only caters to English speaking families,
as do most of the resources we link to and promote.
Themes Found in Survey Responses
Based on feedback from our survey questions, we identified five common themes. The
primary themes these surveys were coded for were the website's aesthetic, language used,
resource choices, how-to guide utility, and the clinical utility of the website as a whole. We took
the qualitative responses and coded them into quantitative figures for each of these themes
every time they were mentioned. For example, anytime a respondent mentioned font size,
organization, layout, text density, and graphics their response was coded as an “aesthetic”
theme. When respondents commented on word choice that was either too sophisticated for the
target audience, or there was grammatical suggestions, it was coded as “language.” When
respondents suggested adding, removing, or editing current resources linked on the website,
their response was coded “resource choice.” Respondents were asked to comment on the howto guides’ ease of use and whether they felt they were helpful in describing each resource: these
were coded as “how-to guide utility.” Lastly, clinical utility was coded every time a respondent
stated they would recommend this resource to a patient and their family.
From these codes aesthetics and language were mentioned the most. Edits made based
on these comments included decreasing text density, increasing font size, and simplifying
language like medical terminology used in the case example case story. We also adjusted the
content of the website based on the feedback coded as resource choice and utility of how-to
guides. We added NORD and Genetic Alliance as additional resources, and altered the

descriptions of PubMed and ClinVar. Any feasible comments were incorporated, while others
were disregarded based on limitations set by the website building platform of Squarespace (i.e.
banner size, menu header font size, layout, and adding a discussion forum). All of the survey
participants responded favourably to the utility of the website as a whole. When asked if the
resource was one they would use in the future, or recommend to patients and families, all of
them responded, “Yes”.
Future Directions
Now that the website and how-to guides have been developed they need to be
evaluated for utility and ease of use. The website needs to be tested by N-of-1 families to ensure
that the content is appropriate and accessible for the general population. The how-to guides will
need to be revised in the future as the primary resources are updated. Additionally, new how-to
guides will need to be developed as more resources and technologies, such as new matchmaker
databases, are created for the rare disease community. We would like to eventually feature
stories of N-of-1 families on our website to both enhance our connection with the target
audience, and create online discussion forums on our website so that families can interact with
others facing similar situations.
Additionally, we need to bring awareness to our website. We plan to contact different
rare disease advocacy organizations in the hopes of partnership and mutual promotion of each
other's resources. In addition to these essential advocacy connections, serious efforts need to
be made in order to promote and advertise this resource. By attending genetics-focused
conferences in the future, we will be able to promote our website to genetics professionals so
that they can provide this resource to N-of-1 families at the time of diagnosis.

This project will continue to evolve to fulfill its full potential and its ultimate goal. We as
a group are excited about DNA Unicorn and its potential to help N-of-1 families.
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Appendix A
Formatting slightly different on website.
Human Phenotype Ontology Guide
PART I: The HPO
One resource that you may find useful is the Human Phenotype Ontology or HPO. The name
alone sounds a bit daunting doesn’t it? The Human Phenotype Ontology is a database that is
trying to help standardize the medical terms used to describe different phenotypes (an
individual’s traits/characteristics/symptoms) associated with human diseases. This resource is
very helpful for scientists and clinicians, but may also be helpful for you. Admittedly, it isn’t the
most user-friendly but hopefully this guide will help you if you are interested in giving it a try.
The HPO can help you in figuring out the medical terms that are used to describe the features
associated with your or your loved one’s disease. Knowing the correct medical terminology can
help you search for others by using these terms and can also help others to find you.
To get to the HPO homepage go to http://human-phenotype-ontology.github.io/. The HPO
homepage is pretty busy and most of it will not be useful to you. There are many different tools
and other databases that use the HPO that you may come across if you explore the HPO
website. Most of these were designed for researchers and are really only useful for that
purpose. To get to where you can search the HPO go to lower right of the homepage.

After clicking on the HPO Browser button you are taken to this page where you can search the
HPO. You can type in the words that you would use to describe the features of your or your
child’s genetic disease.

We will use the example of Anna (see our mock patient story first for the full description of
Anna) to explain how to use the HPO web browser. One unusual feature of Anna’s condition is
an extra thumb. If you type extra thumb into the search bar, the medical terms and/or
descriptions in the HPO database that match it will pop up in blue below. In this case there was
only one option because the words used to search were pretty specific, but sometimes multiple
options will pop up depending on what you entered. We will click on the blue box to select the
HPO term/description to continue.

After selecting a term/description from the list of options in the blue drop down menu you will
be taken to that term’s page. Using our example of extra thumb, we selected the only option
that appeared in the blue drop down menu. In doing this we are taken to the page for “Preaxial
Polydactyly”.

Scrolling down the page you will see several different boxes, each with different information

Let’s do another sample search. Anna was described as having small teeth. When you type small
teeth into the search bar, several matching options appear in the drop down list. We selected
the “Small teeth” option from the list first because it was exactly what we typed in and was the
simplest term/description listed. It may be easiest to always start with the simplest term first.
You could always select one of the other options and explore the page for that term to see if it
fits with what you are trying to describe. If it doesn’t fit, you can always go back and choose
another term from those in the list.

Clicking on the “Small teeth” option takes us to the page for Microdontia. The definition fits with
our description of Anna. If it didn’t seem to fit we would go back and select a different term
from the list.

We will do one final example using Anna’s story. Sometimes you will type in a term and no
options will appear. This means that what was typed in the search bar hasn’t been linked to an
HPO term yet. If this happens you could try using a different description or searching for a
broader term first.

When we removed the word “weak” and kept “tooth enamel” options appeared in the drop
down list. We selected Abnormal tooth enamel.

“Abnormality of dental enamel” fits with what we are trying to describe (weak enamel) about
Anna, but is still a pretty broad term. If the term you end up with seems too broad you can look
for more specific terms by looking at the terms listed under “Subclasses”. You can explore the
different subclasses of terms on HPO using Google. In this case, the term “Hypoplasia of dental
enamel” seems to fit best.

The page for dental enamel hypoplasia doesn’t have a very helpful definition so we had to
Google dental enamel hypoplasia to get a better understanding. The “Synonyms” are helpful, so
remember to look for those when you are trying to understand the definition of a term.

Now you are ready to get started using the HPO! It can feel a bit like trial and error when using
it, especially at first, but it does get easier the more you play around with it. If you are feeling
comfortable with the HPO then check out the Phenomizer (see below), which is a database that
uses the HPO terms.
PART II: The Phenomizer
The Phenomizer is a tool where you can enter the features, signs, and symptoms (the
phenotype) of the affected person in your family to see if there are known diseases that match
with their condition. The Phenomizer was designed for physicians to use to help in diagnosis,
but is open to anyone. That being said, it is not the easiest tool to navigate, and like the HPO it
can take some time to get the hang of it. To access the Phenomizer go to
https://compbio.charite.de/phenomizer/.

Phenomizer uses the HPO database medical terms and applies these to the diseases that are
in the Phenomizer database. It is easiest if you have already used the HPO to create a list of the
medical terms that apply to the features and symptoms of the affected person. You can
sometimes search the Phenomizer using non-HPO words to describe the disease. The HPO terms
will sometimes pop up, but not always, so it’s easiest if you already have them handy. See the
first part of this guide for tips on how to find the HPO terms.

You can also search the Phenomizer database by disease name under the “Diseases” tab if you
have the name of a specific disease and want to see if that disease is in the Phenomizer
database.

If you aren’t sure of the medical/HPO term to describe a symptom you can try to find it under
the “Ontology” tab. This tab has one main folder “ORGAN ABNORMALITY” and many subfolders
within the main folder. If you click on the small arrow next to the main folder it will show you
the subfolders, and the same for each subfolder. The folders are divided by organ systems so
you can search through the folders until you have a term that describes the symptom you are
trying to describe. This can be very time consuming so it’s recommended that you try to find the
medical terms via the HPO first.

We will again use the mock patient Anna to demonstrate how to use the Phenomizer. We will
enter all of Anna’s symptoms and unique features into the Phenomizer, one at a time. One of
the features Anna is described as having is extra thumbs, which we now know is called “preaxial
polydactly” from searching the HPO (see Part 1 of this guide). We will enter “preaxial
polydactyly” into the “Enter feature” bar under the “Features” tab.

We have now selected “Preaxial hand polydactyly. To the right of the screen will be a list of all of
the patient features once you add them. To add a feature to the list on the right you have to
double click the feature on the left.

When you add a feature to the Patient’s Features list the feature may appear in the list under
different categories. Any broader category the feature can fit in will appear in the list. For
example, Preaxial hand polydactyly can fit into the categories “Abnormality of limbs” and
“Abnormality of the skeletal system”, thus both appear in the list.

There are five different possible columns under the Patient’s Features list and you can select
which ones you would like to view or hide. To select which columns you would like to view click
on the arrow next to “HPO”, select “Columns”, and add a checkmark next to the option to view
it or remove the checkmark if you don’t want to see that column. The “Feature” column lists
each feature added to the Patient’s Features list. The “HPO” column lists the HPO ID number for
each feature. The “Num diseases” category lists how many diseases in the Phenomizer database
include this feature.

You can continue adding features by typing them into the “Enter feature” bar on the left and
double clicking on the feature. We have added all of Anna’s features and symptoms to the
Patient’s features list.

Once you have added all of the symptoms/features to the Patient’s features list you can select
the type of genetic inheritance pattern you want to search for when searching for diseases. If
you know how the genetic mutation in the affected individual was inherited you can select the
specific pattern; otherwise, select “any”. When you are ready to search for diseases that fit with
the list of features click on “Get diagnosis” at the bottom right of the page.

A list of possible disease will appear under the “Diseases” tab. The diseases that most closely
match the list of features will be located at the top of the list. The “p-value” is a word used in
statistics, and the lower the p-value the more the disease fits with the list of features. In
statistics if a “p-value” is less than 0.05 this is considered statistically significant -- meaning that
there is a high likelihood that the association between the two things did not happen by chance.
In our example the p-values are all a lot higher than 0.05, meaning there isn’t a significant
relationship and that the diseases listed don’t match well with the list of Patient’s features. You
can always explore some of the diseases by using Google to search for them. Now you have the
basics on how to use both the HPO and the Phenomizer. For more in depth information on the
Phenomizer, download the user manual under the “Help” tab. Good luck!

